Viatris Cash on Hand 2010-2024 | VTRS

Viatris cash on hand from 2010 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Viatris cash on hand for the quarter ending September 30, 2024 was $1.879B, a 43.46% increase year-over-year.
  • Viatris cash on hand for 2023 was $0.992B, a 21.27% decline from 2022.
  • Viatris cash on hand for 2022 was $1.26B, a 79.68% increase from 2021.
  • Viatris cash on hand for 2021 was $0.701B, a 16.96% decline from 2020.
Viatris Annual Cash on Hand
(Millions of US $)
2023 $992
2022 $1,260
2021 $701
2020 $844
2019 $476
2018 $388
2017 $292
2016 $999
2015 $1,236
2014 $226
2013 $291
2012 $350
2011 $375
2010 $715
2009 $456
Viatris Quarterly Cash on Hand
(Millions of US $)
2024-09-30 $1,879
2024-06-30 $917
2024-03-31 $1,015
2023-12-31 $992
2023-09-30 $1,310
2023-06-30 $629
2023-03-31 $507
2022-12-31 $1,260
2022-09-30 $647
2022-06-30 $665
2022-03-31 $752
2021-12-31 $701
2021-09-30 $757
2021-06-30 $674
2021-03-31 $807
2020-12-31 $844
2020-09-30 $665
2020-06-30 $324
2020-03-31 $572
2019-12-31 $476
2019-09-30 $359
2019-06-30 $212
2019-03-31 $230
2018-12-31 $388
2018-09-30 $449
2018-06-30 $330
2018-03-31 $367
2017-12-31 $292
2017-09-30 $615
2017-06-30 $613
2017-03-31 $724
2016-12-31 $999
2016-09-30 $1,257
2016-06-30 $6,362
2016-03-31 $1,199
2015-12-31 $1,236
2015-09-30 $587
2015-06-30 $440
2015-03-31 $277
2014-12-31 $226
2014-09-30 $200
2014-06-30 $194
2014-03-31 $243
2013-12-31 $291
2013-09-30 $365
2013-06-30 $277
2013-03-31 $294
2012-12-31 $350
2012-09-30 $367
2012-06-30 $348
2012-03-31 $298
2011-12-31 $375
2011-09-30 $552
2011-06-30 $490
2011-03-31 $663
2010-12-31 $715
2010-09-30 $665
2010-06-30 $881
2010-03-31 $599
2009-12-31 $456
2009-09-30 $682
2009-06-30 $516
2009-03-31 $533
Sector Industry Market Cap Revenue
Medical Medical Services $14.478B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.995B 10.55
Cencora (COR) United States $43.734B 16.44
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $20.871B 0.00
ICON (ICLR) Ireland $16.879B 15.03
Avantor (AVTR) United States $14.307B 21.45
Revvity (RVTY) United States $13.453B 23.37
BioMerieux (BMXMF) France $12.659B 0.00
CochLear (CHEOY) Australia $11.807B 0.00
Solventum (SOLV) United States $11.540B 0.00
Medpace Holdings (MEDP) United States $10.417B 29.35
Doximity (DOCS) United States $10.302B 60.64
Charles River Laboratories (CRL) United States $9.314B 18.00
HealthEquity (HQY) United States $8.212B 41.20
Sonic Healthcare (SKHHY) Australia $8.208B 0.00
Bausch + Lomb (BLCO) Canada $6.322B 29.43
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.759B 20.11
Organon (OGN) United States $3.719B 3.75
BrightSpring Health Services (BTSG) United States $2.967B 63.11
Surgery Partners (SGRY) United States $2.493B 28.42
Concentras Parent (CON) United States $2.491B 0.00
Ardent Health Partners (ARDT) United States $2.291B 0.00
GeneDx Holdings (WGS) United States $2.069B 0.00
Premier (PINC) United States $2.067B 10.76
PACS (PACS) United States $1.992B 0.00
Alignment Healthcare (ALHC) United States $1.969B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.730B 0.00
GoodRx Holdings (GDRX) United States $1.711B 44.90
Teladoc Health (TDOC) United States $1.544B 0.00
Pediatrix Medical (MD) United States $1.224B 11.98
Progyny (PGNY) United States $1.208B 24.47
Embecta (EMBC) United States $1.161B 8.12
CareDx (CDNA) United States $1.102B 0.00
Establishment Labs Holdings (ESTA) $1.090B 0.00
AMN Healthcare Services Inc (AMN) United States $0.874B 5.91
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.775B 0.00
SBC Medicals (SBC) United States $0.649B 0.00
Auna S.A (AUNA) Luxembourg $0.492B 0.00
InnovAge Holding (INNV) United States $0.478B 0.00
DocGo (DCGO) United States $0.444B 16.73
Sonida Senior Living (SNDA) United States $0.441B 0.00
Enhabit (EHAB) United States $0.387B 33.48
Sera Prognostics (SERA) United States $0.275B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.268B 0.00
LifeMD (LFMD) United States $0.212B 0.00
Biodesix (BDSX) United States $0.198B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
Nutex Health (NUTX) United States $0.160B 0.00
ModivCare (MODV) United States $0.156B 8.44
MultiPlan (MPLN) United States $0.108B 0.00
Ascend Wellness Holdings (AAWH) United States $0.099B 0.00
So-Young (SY) China $0.093B 15.69
IceCure Medical (ICCM) Israel $0.052B 0.00
Singular Genomics Systems (OMIC) United States $0.050B 0.00
OncoCyte (OCX) United States $0.037B 0.00
NeueHealth (NEUE) United States $0.033B 0.87
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.023B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
KindlyMD (KDLY) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Cano Health (CANOQ) United States $0.001B 0.00
Aclarion (ACON) United States $0.001B 0.00